Novartis
(https://lutathera.com) 📸 Data Snapshot: May 31, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Authority is firmly established through the Novartis Organization schema, which includes sameAs links to the global corporate site. Technical implementation is clean, with a clear heading hierarchy that prioritizes Safety Information and Approved Use, satisfying regulatory expectations. There are no claims of ‘unnamed experts’; the authority is the brand and the clinical data itself.
Performance claims like ‘slow down NET progression for longer’ are specific and medically defined rather than marketing hyperbole. The disconnect is minimal, as the site provides the specific patient populations (those progressing on SSAs) for whom these results are applicable. The site demonstrates exactly what the drug does (Mechanism of Action) rather than making vague ‘life-changing’ assertions without context.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
{
"@context": "https://schema.org",
"@type": "Organization",
"@id": "https://us.lutathera.com/#Organization",
"name": "Novartis",
"url": "https://www.novartis.com/us-en/",
"logo": "https://usim.beprod.lutathera.com/sites/us_lutathera_com/files/icons/2026-02/logo.svg",
"description": "Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.",
"makesOffer": {
"@type": "Offer",
"@id": "https://us.lutathera.com/#makesOffer",
"name": "Lutathera",
"alternateName": "lutetium Lu 177 dotatate",
"availability": "https://schema.org/PrescriptionOnly",
"sameAs": "https://us.lutathera.com/patient-support/novartis-patient-support#offer"
}
}
/patient-support/find-a-treatment-site/
{
"@context": "https://schema.org",
"@type": "Organization",
"@id": "https://us.lutathera.com/#Organization",
"name": "Novartis",
"url": "https://www.novartis.com/us-en/",
"logo": "https://usim.beprod.lutathera.com/sites/us_lutathera_com/files/icons/2026-02/logo.svg",
"description": "Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.",
"makesOffer": {
"@type": "Offer",
"@id": "https://us.lutathera.com/#makesOffer",
"name": "Lutathera",
"alternateName": "lutetium Lu 177 dotatate",
"availability": "https://schema.org/PrescriptionOnly",
"sameAs": "https://us.lutathera.com/patient-support/novartis-patient-support#offer"
}
}
/about-gep-net/early-action/
{
"@context": "https://schema.org",
"@type": "Organization",
"@id": "https://us.lutathera.com/#Organization",
"name": "Novartis",
"url": "https://www.novartis.com/us-en/",
"logo": "https://usim.beprod.lutathera.com/sites/us_lutathera_com/files/icons/2026-02/logo.svg",
"description": "Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.",
"makesOffer": {
"@type": "Offer",
"@id": "https://us.lutathera.com/#makesOffer",
"name": "Lutathera",
"alternateName": "lutetium Lu 177 dotatate",
"availability": "https://schema.org/PrescriptionOnly",
"sameAs": "https://us.lutathera.com/patient-support/novartis-patient-support#offer"
}
}
/sitemap/
{
"@context": "https://schema.org",
"@type": "Organization",
"@id": "https://us.lutathera.com/#Organization",
"name": "Novartis",
"url": "https://www.novartis.com/us-en/",
"logo": "https://usim.beprod.lutathera.com/sites/us_lutathera_com/files/icons/2026-02/logo.svg",
"description": "Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.",
"makesOffer": {
"@type": "Offer",
"@id": "https://us.lutathera.com/#makesOffer",
"name": "Lutathera",
"alternateName": "lutetium Lu 177 dotatate",
"availability": "https://schema.org/PrescriptionOnly",
"sameAs": "https://us.lutathera.com/patient-support/novartis-patient-support#offer"
}
}
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 1 |
| /patient-support/find-a-treatment-site/ | 0 | 1 |
| /about-gep-net/early-action/ | 0 | 1 |
| /sitemap/ | 0 | 1 |
This page presents a snapshot of public data from Novartis, captured on May 31, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Novartis: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://lutathera.com to view the most current version of its content and see directly what this company is about and what it offers.